logo

For the Inventor, By the Inventor

Summit, NJ, United States of America

Celgene Corporation


USPTO Granted Patents = 561

% Expired Patents = 17.8



Trademarks = 103

Forward Citations = 8,896

Loading Chart...
Loading Chart...

502 inventors (with patents filed for the assignee):

goldMedal George W Muller (162 out of 172 patents)

silverMedal Hon-Wah Man (112 out of 128 patents)

bronzeMedal Jerome B Zeldis (56 out of 63 patents)

4.  Roger Shen-Chu Chen (50 out of 53 patents)

5.  Alexander L Ruchelman (36 out of 56 patents)

6.  Peter Henry Schafer (36 out of 40 patents)

7.  David I Stirling (36 out of 43 patents)

8.  Antonia Lopez-Girona (32 out of 40 patents)

9.  Joshua Hansen (31 out of 42 patents)

10.  Chuansheng Ge (25 out of 28 patents)

11.  Matthew Daniel Correa (25 out of 28 patents)

12.  Weihong Zhang (24 out of 25 patents)

13.  John Fitzgerald Traverse (21 out of 31 patents)

14.  Ho-Wah Hui (20 out of 24 patents)

15.  Mary Shire (20 out of 20 patents)


Core Competencies:
Combination Therapy
Cereblon Binding
Biomarkers
Antibody Engineering
Neurodegenerative Diseases
Hematological Malignancies
Antiproliferative Compounds
Small Molecule Affinity
Isoindoline Compounds
T Lymphocytes
Pharmaceutical Compositions

561 patents:

1. 12734170 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2026-09-15),
2. 12715869 - Modulators of CAMKK2 as ligand directed degraders (2026-08-25),
3. 12668598 - MK2 INHIBITORS AND USES THEREOF (2026-06-30),
4. RE50917 - Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione (2026-06-16),
5. 12624003 - Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases (2026-05-12),
6. 12605372 - Combination therapy for the treatment of cancer (2026-04-21),
7. 12590953 - METHODS FOR SCREENING CEREBLON MODIFYING COMPOUNDS (2026-03-31),
8. 12583837 - Solid forms comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and salts thereof, and compositions comprising and methods of using the same (2026-03-24),
9. 12577223 - Processes for preparing 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide (2026-03-17),
10. 12552771 - Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases (2026-02-17),
11. 12545740 - ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47 (2026-02-10),
12. 12510533 - Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile (2025-12-30),
13. 12486281 - Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith (2025-12-02),
14. 12474342 - Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies (2025-11-18),
15. 12472176 - Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same (2025-11-18),
Celgene Corporation, headquartered in Summit, NJ, specializes in the development of innovative therapies for cancer treatment. The company focuses on combination therapies and leverages advanced technologies such as antibody engineering and small molecule affinity to address hematological malignancies and neurodegenerative diseases. Celgene is committed to enhancing patient outcomes through the identification of biomarkers and the development of antiproliferative compounds, positioning itself as a leader in the oncology sector.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Celgene Corporation
561 Patents

#1 in Summit, NJ

#48 in New Jersey

#871 in US

#1,728 in the World

Summit, NJ (US)
Summit, NJ, United States of America

Celgene Corporation

Forward Citations = 8,896

502 inventors:

goldMedal George W Muller (162 out of 172 patents)

silverMedal Hon-Wah Man (112 out of 128 patents)

bronzeMedal Jerome B Zeldis (56 out of 63 patents)

4.  Roger Shen-Chu Chen (50 out of 53 patents)

5.  Alexander L Ruchelman (36 out of 56 patents)

Please report any incorrect information to [email protected]
Loading…